Position in PTGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$16,542,171
-$2,819,809 QoQ
Shares Held
134,950
-26.5% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 341 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. PTGX ranks #16 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,542,171 | 134,950 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $19,361,980 | 183,700 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $13,863,478 | 158,730 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,992,932 | 150,428 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,429,669 | 116,332 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $8,217,911 | 169,932 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,704,897 | 173,702 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,749,090 | 172,202 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,138,664 | 148,302 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,137,516 | 108,452 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,540,644 | 110,800 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,848,144 | 110,800 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,530,148 | 55,400 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $667,000 | 29,000 | Shares | Sole | 2023-05-10 | |
| 2022-03-31 | $422,498 | 17,842 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,130,036 | 33,042 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $833,584 | 47,042 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,089,628 | 68,842 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,592,098 | 61,471 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,033,240 | 51,252 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $769,351 | 39,353 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $694,973 | 39,353 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||